Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001;2(6):263-265.
doi: 10.1186/cvm-2-6-263.

Debate: PCI vs CABG: a moving target, but we are gaining

David R Holmes Jr  1
Affiliations

Debate: PCI vs CABG: a moving target, but we are gaining

David R Holmes Jr. Curr Control Trials Cardiovasc Med. 2001.

Abstract

The treatment of patients with coronary artery disease continues to evolve; all three strategies - medical therapy, surgical revascularization, and percutaneous coronary intervention - have changed. Medical therapy with intense risk-factor modification and treatment with a statin, aspirin, and angiotensin-converting enzyme (ACE) inhibitors, should be used unless contraindicated. Surgical therapy has also changed with the introduction of minimally invasive, beating heart surgery. Percutaneous coronary intervention has perhaps changed the most radically with adjunctive therapy - glycoprotein IIb/IIIa inhibitors, thienopyridines, and reliance on stent implantation. The future, with new distal protection devices and drug-coated stents, should continue to see increased numbers of patients who can benefit from percutaneous intervention.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators Seven-year outcome in the bypass angioplasty revascularization investigation (BARI) by treatment and diabetes status. J Am Coll Cardiol. 2000;35:1122–1129. doi: 10.1016/S0735-1097(00)00533-7. - DOI - PubMed
    1. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier H, Schönberger JPAM, Buller N, Bonser R, Marcel JB, van den Brand MCB, van Herwerden LA, Morel M-AM, van Hout BA, for the Arterial Revascularization Therapies Study Group Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117–1124. doi: 10.1056/NEJM200104123441502. - DOI - PubMed
    1. Stables RH. Stent or Surgery (SoS): Randomized trial tests bypass surgery against coronary stenting for multivessel disease. Presented at the American College of Cardiology 50th Annual Scientific Sessions. http://www.acc.org/media/session_info/late/ACC2001/index.htm March 18-21, 2001.
    1. Huey W. Medicine, Angioplasty, or Surgery Study (MASS II) Trial: compares surgery, angioplasty, and drug therapy for mul-tivessel heart disease. Presented at the American College of Cardiology 50th Annual Scientific Sessions. http://www.acc.org/media/session_info/late/ACC2001/index.htm March 18-21, 2001.
    1. Henderson RA, Pocock SJ, Sharp SJ, Nanchahal K, Sculpher MJ, Buxton MJ, Hampton JR. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomized Intervention Treatment of Angina. Lancet. 1998;352:1419–1425. doi: 10.1016/S0140-6736(98)03358-3. - DOI - PubMed

LinkOut - more resources